MARCKS and breast cancer: The combination treatment of paclitaxel and MANS peptide demonstrated here both in vitro and in vivo studies suggests that MANS or a similar peptide that blocks paclitaxel-mediated elevation of phospho-MARCKS could be further tested in clinical trials as an adjuvant to chemotherapeutics for breast cancer.